April 30, 2023
Clinical Outcomes
Coverage and Benefit Design
Article / Publication
Learn More
Share:

April 11, 2023
Clinical Outcomes
Economic Outcomes
Article / Publication
Learn More
Share:

March 17, 2023
Economic Outcomes
CGM Best Practices / Interview

Expert: Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, Endocrine Clinical Pharmacy Specialist, Co-Director, Endocrine Disorders in Pregnancy, Cleveland Clinic Endocrinology & Metabolism Institute

Summary: Opportunities to improve care quality and reduce costly resource utilization in diverse patient populations with evidence-based utilization of CGM

Share:

March 2, 2023
Coverage and Benefit Design
Guidelines / Policy

The Centers for Medicare and Medicaid Services (CMS) expanded CGM access to beneficiaries on basal-only insulin or those with a history of level two or three hypoglycemia. Although the Local Coverage Determination (LCD) was originally anticipated to be implemented in July, CMS expanded access to CGM on April 16, 2023. This new coverage policy is aligned with consensus guidelines from the ADA and AACE, which recommend CGM for all patients on insulin at the outset of diagnosis. The new LCD, which was proposed in 2022, also removes the term “daily” as a descriptor for insulin to account for potential FDA approval of weekly insulins in the future.

Learn More
Share:

March 2, 2023
Population Health
CE Activities

Intended Audience: This activity is designed to meet the educational needs of medical directors, registered nurses, pharmacy directors, clinical pharmacists, specialty pharmacists, quality directors, as well as network physicians affiliated with various MCOs, health systems, and other payer organizations.

Credit Available: Up to 0.5 credit hour available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)

Expiration Date:  August 31, 2024

Click here to begin!

Educational Objectives
After completing this activity, the participant should be better able to:

  • Describe the clinical outcomes of real-time continuous glucose monitoring initiation in insulin-treated patients with diabetes
  • Access health plan opportunities to improve diabetes outcomes for patients with diabetes based on current treatment guidelines and quality measures
  • Identify how multi-disciplinary care teams can support quality improvement interventions for patients with diabetes

Expert Faculty

Richard Dlott, MD

Managing Director

FourthFlight

Jeffrey Dunn, PharmD, MBA

Chief Clinical Officer

Cooperative Benefits Group

Jointly provided by Impact Education, LLC, and Medical Education Resources.
This continuing education activity is supported by an independent educational grant from Dexcom, Inc.

Share:

February 28, 2023
Clinical Outcomes
Coverage and Benefit Design
Article / Publication

Learn More
Share:

February 17, 2023
CGM Technology and Digital Health
CGM Innovations / Webinar / Archive

Click here to download the summary from this live event or watch the webinar video archive below.

Share:

February 17, 2023
Clinical Outcomes
Article / Publication
Learn More
Share:

February 16, 2023
Population Health
CE Activities

Intended Audience: This activity is designed to meet the educational needs of medical directors, registered nurses, pharmacy directors, clinical pharmacists, specialty pharmacists, quality directors, as well as network physicians affiliated with various MCOs, health systems, and other payer organizations.

Credit Available: Up to 0.5 credit hour available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)

Expiration Date:  June 30, 2024

Click here to begin!

Educational Objectives
After completing this activity, the participant should be better able to:

  • Describe the risks of hypoglycemia in older patients with diabetes
  • Access health plan opportunities to identify underserved populations with diabetes, address the risks of hypoglycemia, and to implement appropriate interventions for prevention of hypoglycemia in high-risk populations
  • Identify steps for the delivery of successful quality improvement interventions in diabetes and the role of real-time continuous glucose monitoring

Expert Faculty

Estay Greene, PharmD, MBA

Vice President of Pharmacy

Zing Health

Jeffrey Dunn, PharmD, MBA

Chief Clinical Officer

Cooperative Benefits Group

Jointly provided by Impact Education, LLC, and Medical Education Resources.
This continuing education activity is supported by an independent educational grant from Dexcom, Inc.

Share:

January 25, 2023
CGM Technology and Digital Health
CGM Innovations

A task analysis and ease of use survey conducted among adults aged ≥65 years and certified diabetes care and education specialists (CDCESs) showed excellent useability associated with the new G7 RT-CGM system. Ease of use related to intradermal insertion and mobile app setup were assessed and compared to the fifth- and sixth-generation systems in the study, which recruited 10 older adults with no previous CGM experience and 10 CDCESs. The analysis revealed that approximately half as many tasks are needed to deploy the G7 system compared with the G6, resulting in excellent usability as assessed by older adults and CDCESs in the study, highlighted by a system usability score of 92.8. Cumulatively, these findings indicate a relatively low cognitive burden associated with the system compared with previous versions, simplifying the utilization of RT-CGM for older adults who are at higher risk for diabetes-related complications and stand to benefit from the implementation of diabetes technology. Managed care and payer decision makers may find the data presented in the study useful for informing coverage policy and criteria for RT-CGM in this vulnerable population of patients.

Psavko S, Katz N, Mirchi T, Green CR. Usability and Teachability of Continuous Glucose Monitoring Devices in Older Adults and Diabetes Educators: Task Analysis and Ease-of-Use Survey. JMIR Hum Factors. 2022;9(4):e42057.

1. Psavko S et al. JMIR Hum Factors 2022;9(4):42057
Learn More
Share: